Kilitch Drugs (India) Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 13, 2026
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kilitch Drugs held an Extraordinary General Meeting on March 13, 2026 via video conferencing, which concluded within 12 minutes (11:30 am to 11:42 am). Two key resolutions were transacted: (1) an increase in the authorized share capital of the company along with a corresponding amendment to the Capital Clause of the Memorandum of Association, and (2) approval for the issue and allotment of Bonus Shares in a 1:1 ratio to existing shareholders, with the record date to be decided by the Board. A total of 48 members attended the meeting (3 from the promoter group and 45 from the public). Detailed voting results and the Scrutinizer's Report are to be shared with the stock exchanges and uploaded on the company's website in due course.
The 1:1 bonus issue is a significant corporate action that will double the number of outstanding shares held by each shareholder, improving liquidity and affordability of the stock. While the share price is expected to adjust downward on an ex-bonus basis, the overall value of holdings remains unchanged. The bonus signals management's confidence in the company's financial position and is generally viewed positively by retail investors.